Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

Airline Stocks: What’s Moving DAL, AAL and UAL Today

By Robert Lakin, InvestorPlace Contributor

Airline stocks are starting to breathe a sigh of relief. But it might be too soon, as Covid-19 and the delta variant threaten travel.

CLOV Stock: Why One Analyst Is Now Souring on Clover Health

By Robert Lakin, InvestorPlace Contributor

JPMorgan told clients to "underweight" Clover Health after the Medicare management firm lowered most guidance metrics. It knocked the CLOV stock price target down to $9 a share.

NOK Stock: The Big News That Has the Reddit Favorite Gaining Today

By Robert Lakin, InvestorPlace Contributor

Meme favorite Nokia will raise its full-year outlook as business picked up in the second quarter. That's got NOK stock surging ahead of Tuesday's U.S. market open.

LCAP Stock: What to Know About Lionheart Acquisition and the MSP Recovery SPAC Merger

By Robert Lakin, InvestorPlace Contributor

News of the Lionheart-MSP deal comes as more than 420 SPACs are now searching for a private company to take public and another 295 with pending IPOs. Will this be what takes LCAP stock higher?

Space Stocks: The Milestone That Has VACQ, ASTR, ASTS Stocks Gaining Today

By Robert Lakin, InvestorPlace Contributor

The Virgin Galactic flight is being heralded as a milestone for commercial space flight. That's got space stocks ASTS, ASTR and VACQ gaining in Monday's pre-market trading.

Load More